Moreover, Signorelli et al. [18] identified the risk of DVT by using routine blood tests, such as erythrocyte sedimentation rate, antithrombin III, C-reactive protein, D-dimer, and N-terminal pro-brain natriuretic peptide, in 295 consecutive medical patients. This evidence concerns the gene SERPINC1 and deep vein thrombosis.